BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15150775)

  • 1. Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development.
    Royer-Pokora B; Beier M; Henzler M; Alam R; Schumacher V; Weirich A; Huff V
    Am J Med Genet A; 2004 Jun; 127A(3):249-57. PubMed ID: 15150775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
    Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
    Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.
    Schumacher V; Schneider S; Figge A; Wildhardt G; Harms D; Schmidt D; Weirich A; Ludwig R; Royer-Pokora B
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3972-7. PubMed ID: 9108089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
    Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
    Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1 gene analysis in sporadic early-onset and bilateral wilms tumor patients without associated abnormalities.
    Perotti D; Mondini P; Terenziani M; Spreafico F; Collini P; Fossati-Bellani F; Radice P
    J Pediatr Hematol Oncol; 2005 Apr; 27(4):197-201. PubMed ID: 15838390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
    Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
    J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.
    Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B
    Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes).
    Auber F; Lortat-Jacob S; Sarnacki S; Jaubert F; Salomon R; Thibaud E; Jeanpierre C; Nihoul-Fékété C
    J Pediatr Surg; 2003 Jan; 38(1):124-9; discussion 124-9. PubMed ID: 12592634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.
    Lehnhardt A; Karnatz C; Ahlenstiel-Grunow T; Benz K; Benz MR; Budde K; Büscher AK; Fehr T; Feldkötter M; Graf N; Höcker B; Jungraithmayr T; Klaus G; Koehler B; Konrad M; Kranz B; Montoya CR; Müller D; Neuhaus TJ; Oh J; Pape L; Pohl M; Royer-Pokora B; Querfeld U; Schneppenheim R; Staude H; Spartà G; Timmermann K; Wilkening F; Wygoda S; Bergmann C; Kemper MJ
    Clin J Am Soc Nephrol; 2015 May; 10(5):825-31. PubMed ID: 25818337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations.
    Chernin G; Vega-Warner V; Schoeb DS; Heeringa SF; Ovunc B; Saisawat P; Cleper R; Ozaltin F; Hildebrandt F;
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1655-62. PubMed ID: 20595692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome.
    Gao F; Maiti S; Sun G; Ordonez NG; Udtha M; Deng JM; Behringer RR; Huff V
    Mol Cell Biol; 2004 Nov; 24(22):9899-910. PubMed ID: 15509792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral Wilms tumor and early presentation in pediatric patients is associated with the truncation of the Wilms tumor 1 protein.
    Hu M; Fletcher J; McCahon E; Catchpoole D; Zhang GY; Wang YM; Algar EM; Alexander SI
    J Pediatr; 2013 Jul; 163(1):224-9. PubMed ID: 23403252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
    Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
    Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
    Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
    Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pathological features of Denys-Drash syndrome: report of 3 cases].
    Wang HY; Sun LZ; Yue ZH; Yang J; Jiang XY; Mo Y
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):855-8. PubMed ID: 23302619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of two female patients with incomplete Denys-Drash syndrome.
    Ohta S; Ozawa T; Shiraga H; Fuse H
    Endocr J; 2000 Dec; 47(6):683-7. PubMed ID: 11228042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited WT1 mutation in Denys-Drash syndrome.
    Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
    Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
    Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
    Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.